Zhenquiang Lu

Title: The Innovations of Zhenquiang Lu

Introduction

Zhenquiang Lu is a prominent inventor based in Tucson, AZ (US). He has made significant contributions to the field of molecular diagnostics, particularly in the study of melanocytic lesions. His work focuses on developing methods to differentiate between benign and malignant conditions, which is crucial for effective patient management.

Latest Patents

Zhenquiang Lu holds a patent titled "Molecular malignancy in melanocytic lesions." This patent discloses methods for determining whether a melanocyte-containing sample, such as a nevus or other pigmented lesion, is benign or a primary melanoma. The methods include detecting the expression of at least two disclosed genes at the molecular level, such as mRNA, miRNA, or protein, in a biological sample obtained from a subject. Additionally, the patent provides arrays and kits that can be utilized with these methods.

Career Highlights

Throughout his career, Zhenquiang Lu has worked with notable organizations, including Htg Molecular Diagnostics, Inc. and the John Wayne Cancer Institute. His experience in these institutions has allowed him to advance his research and contribute to the understanding of cancer diagnostics.

Collaborations

Zhenquiang Lu has collaborated with esteemed colleagues, including Hui Wang and Christopher Roberts. These partnerships have further enriched his research and innovation in the field.

Conclusion

Zhenquiang Lu's contributions to molecular diagnostics, particularly in the realm of melanocytic lesions, highlight his role as an influential inventor. His patent and collaborations reflect his commitment to advancing medical science and improving patient outcomes.